Corcept Therapeutics Incorporated (CORT) vs Cytokinetics, Incorporated (CYTK)
- Corcept Therapeutics Incorporated CORT 72.87 +1.73%
- Cytokinetics, Incorporated CYTK 54.95 −1.08%
Corcept Therapeutics Incorporated and Cytokinetics, Incorporated are both Biotechnology companies. Corcept Therapeutics Incorporated and Cytokinetics, Incorporated are of similar size ($7.8B and $7.7B). Cytokinetics, Incorporated has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 47.5×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 30.0% against 29.9%. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs −686.6%) and the higher return on invested capital (15.0% vs 0.00%). Across the 18 metrics below, Corcept Therapeutics Incorporated leads on 13 and Cytokinetics, Incorporated on 5.
Valuation
Profitability
| Metric | CORT | CYTK | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.54% | 0.00% | 65.16% |
| Operating margin | 11.51% | (625.15%) | 0.00% |
| Net margin | 16.54% | (686.63%) | 0.00% |
| Free cash flow margin | 20.20% | (519.53%) | 0.00% |
| Return on equity | 21.74% | 184.71% | (50.12%) |
| Return on assets | 17.16% | (47.70%) | (45.60%) |
| Return on invested capital | 14.97% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack